K777 is a synthetic cysteine protease inhibitor, originally developed as a potential therapeutic agent for treating Chagas disease and investigating inflammatory pathways. As a potent, irreversible inhibitor… Read more
K777 is a synthetic cysteine protease inhibitor, originally developed as a potential therapeutic agent for treating Chagas disease and investigating inflammatory pathways. As a potent, irreversible inhibitor of enzymes like cruzain and various cathepsins, this compound is primarily utilized in research to study protease-mediated disease mechanisms, viral cell entry, and immune response modulation. Laboratories involved in preclinical research, analytical development, and pharmaceutical quality control rely on related products in this category, including K777 impurities, metabolites, and stable isotope labelled standards. These high-quality reference standards are essential for impurity profiling, the validation of analytical methods such as liquid chromatography-mass spectrometry, and ensuring accuracy in pharmacokinetic studies. By providing the necessary materials for characterizing the drug substance and its degradants, these products support rigorous testing and method development protocols in scientific and clinical research environments.